LW

Lawrence P. Wennogle

IT Intra-Cellular Therapies: 98 patents #2 of 40Top 5%
TU The Rockefeller University: 1 patents #330 of 698Top 50%
📍 Steamboat Springs, CO: #1 of 99 inventorsTop 2%
🗺 Colorado: #90 of 40,980 inventorsTop 1%
Overall (All Time): #15,046 of 4,157,543Top 1%
98
Patents All Time

Issued Patents All Time

Showing 1–25 of 98 patents

Patent #TitleCo-InventorsDate
12409176 Methods of treating acute depression Gretchen SNYDER, Robert E. Davis 2025-09-09
12396992 Organic compounds Gretchen SNYDER, Jennifer O'BRIEN, Joseph Hendrick, Robert E. Davis 2025-08-26
12384783 Salts and crystals Peng Li, Edwin Aret 2025-08-12
12269825 Organic compounds Sharon Mates, Peng Li, Robert E. Davis 2025-04-08
12264160 Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders Peng Li, Qiang Zhang, Robert E. Davis 2025-04-01
12240850 Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders Peng Li, Qiang Zhang, Robert E. Davis 2025-03-04
12139490 Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one John Charles Tomesch, Peng Li, Wei Yao, Qiang Zhang, James David Beard +2 more 2024-11-12
12023331 Methods Gretchen SNYDER, Robert E. Davis 2024-07-02
11980617 Methods of treating acute depression and/or acute anxiety Gretchen SNYDER, Robert E. Davis 2024-05-14
11958852 Compounds and methods Sharon Mates, Robert E. Davis, Kimberly VANOVER 2024-04-16
11839614 Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression David Kass, Toru HASHIMOTO, Joseph Hendrick, Robert E. Davis 2023-12-12
11759465 Uses David Kass, Toru HASHIMOTO, Joseph Hendrick, Robert E. Davis 2023-09-19
11680065 Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system Peng Li, Qiang Zhang, Robert E. Davis 2023-06-20
11560382 Organic compounds Sharon Mates, Peng Li, Robert E. Davis 2023-01-24
11504372 Uses 2022-11-22
11491150 Organic compounds Peng Li, Youyi Peng, Qiang Zhang 2022-11-08
11440911 Salts and crystals Peng Li, Edwin Aret 2022-09-13
11291666 Uses Gretchen SNYDER, Jennifer O'BRIEN, Joseph Hendrick 2022-04-05
RE48839 Methods and compositions for sleep disorders and other disorders Sharon Mates, Allen A. Fienberg 2021-12-07
RE48825 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms John Charles Tomesch 2021-11-23
11166956 Combinations of PDE1 inhibitors and NEP inhibitors Peng Li 2021-11-09
11124514 Compositions and methods Sharon Mates, Robert E. Davis, Kimberly VANOVER 2021-09-21
11066407 Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof John Charles Tomesch, Peng Li, Wei Yao, Qiang Zhang, James David Beard +2 more 2021-07-20
11026951 Methods of treating bipolar disorder Kimberly VANOVER, Peng Li, Sharon Mates, Robert E. Davis 2021-06-08
10960010 Pharmaceutical compositions for sustained or delayed release Kimberly VANOVER, Peng Li, Sharon Mates, Robert E. Davis 2021-03-30